Local control and risk factors of rectal cancer recurrences

Summary. Improving treatment results of rectal cancer and it’s effectiveness is determined by the significant increase of morbidity (20.1 cases per 100.000 in the year 2004, 21.2 — in 2013), insufficient 5-year survival (31.2% — in Ukraine, 38.8 — 59.9 in Western Europe, 65.0 — in USA in 2008), low rate of curative surgery performed, high incidence of pelvic recurrence, complicated social and occupational rehabilitation. Albeit the improvement of treatment, rectal cancer mortality has a second place in a structure of malignancy-specific mortality.